Volume 78, Issue 6, Pages (September 2010)

Slides:



Advertisements
Similar presentations
Acid-base profile in patients on PD
Advertisements

Kidney International, Vol. 68 (2005) 840–846
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Reduced renal function in patients with simple renal cysts
Volume 66, Issue 6, Pages (December 2004)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Use of hemodialysis and hemoperfusion in poisoned patients
Marlies Noordzij, Kitty J. Jager  Kidney International 
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Acid-base profile in patients on PD
Volume 84, Issue 5, Pages (November 2013)
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
C-reactive protein and dialysis access
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 69, Issue 5, Pages (March 2006)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
C-reactive protein and dialysis access
Ho-Han Wu, Szu-Yuan Li, Wu-Chang Yang  Kidney International 
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 59, Issue 1, Pages (January 2001)
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Better nephrology for mice—and man
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
Pasquale Esposito, Teresa Rampino, Giuseppe Sileno, Antonio Dal Canton 
Volume 80, Issue 9, Pages (November 2011)
V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli 
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
Measuring transport of water across the peritoneal membrane
What really happens to people on long-term peritoneal dialysis?
Volume 84, Issue 3, Pages (September 2013)
Volume 76, Issue 10, Pages (November 2009)
Volume 73, Pages S5-S17 (April 2008)
The analysis of survival data: the Kaplan–Meier method
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 58, Issue 2, Pages (August 2000)
Volume 54, Issue 2, Pages (August 1998)
Peritoneal dialysis adequacy and risk of death
Volume 76, Issue 6, Pages (September 2009)
Volume 68, Issue 2, Pages (August 2005)
Volume 74, Issue 8, Pages (October 2008)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function  S.L.S. Fan, T. Pile, S. Punzalan, M.J.
Future of icodextrin as an osmotic agent in peritoneal dialysis
Reduced renal function in patients with simple renal cysts
Volume 78, Issue 5, Pages (September 2010)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1  F. Illies, K.-E. Bonzel, A.-M. Wingen, K. Latta,
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 69, Issue 1, Pages (January 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Quantification of free water transport in peritoneal dialysis
Volume 87, Issue 3, Pages (March 2015)
Volume 65, Issue 1, Pages (January 2004)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 65, Issue 5, Pages (May 2004)
Volume 58, Issue 4, Pages (October 2000)
Volume 57, Issue 4, Pages (April 2000)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Presentation transcript:

Volume 78, Issue 6, Pages 611-618 (September 2010) The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made  Mark L. Lambie, Biju John, Lily Mushahar, Christopher Huckvale, Simon J. Davies  Kidney International  Volume 78, Issue 6, Pages 611-618 (September 2010) DOI: 10.1038/ki.2010.186 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier plot of encapsulating peritoneal sclerosis (EPS) free survival. The probability of remaining free of EPS with duration of time on peritoneal dialysis (PD). This includes two early cases associated with severe, prolonged peritonitis. The number of patients at risk at the time of each case of EPS is shown at the top. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Change in membrane solute transport with time on peritoneal dialysis (PD). Solute transport is measured as the mean annual dialysate/plasma (D/P) creatinine ratio measured at 4h in standard peritoneal equilibration tests with standard error. The star indicates a difference between groups with P=0.007. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Change in ultrafiltration capacity with time on peritoneal dialysis (PD). The ultrafiltration (UF) capacity is the annual mean measured by a 4h peritoneal equilibration test with 2.27% glucose, including approximately 200ml overfill. Bars represent standard error. The stars indicate a difference between groups with P<0.05, unpaired t-test. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Change in membrane solute transport with change in ultrafiltration. Membrane solute transport and ultrafiltration (UF) are measured as the annual mean of measurements of UF capacity and dialysate/plasma (D/P) creatinine ratio in a 4h peritoneal equilibration test with 2.27% glucose, including approximately 200ml overfill. Bars represent standard error. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Glucose exposure with time on peritoneal dialysis (PD). Glucose exposure is measured as the mean of the total number of grams of glucose in the dialysate used by each patient in that year. Bars represent standard error. The stars indicate a difference between groups with P<0.05, unpaired t-test. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Residual renal function with time on peritoneal dialysis (PD). The residual renal function is measured as the median of the urine volume within each group assessed every 6 months from the start of PD. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 Peritoneal protein clearance with time on peritoneal dialysis (PD). Peritoneal protein clearance is measured in ml of plasma per day and the bars represent standard errors. There were no significant differences between the groups when applying mixed linear modeling. Kidney International 2010 78, 611-618DOI: (10.1038/ki.2010.186) Copyright © 2010 International Society of Nephrology Terms and Conditions